Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON
  1. Startseite
  2. Aktien
  3. Kanada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Entheon Biomedical Corp.
  6. News
  7. Andere Sprachen
    ENBI   CA29383X1033

ENTHEON BIOMEDICAL CORP.

(A2QJBZ)
ÜbersichtKurseChartsNewsUnternehmenFinanzenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über ENTHEON BIOMEDICAL CORP.
23.09.MICRODOSE PSYCHEDELIC INSIGHTS ANNOU : September 30, 2021
01.09.LEADING DMT COMPANIES TO TAKE STAGE : DMT Conference
30.08.Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into t..
25.08.Entheon Biomedical Corp. Appoints David Erritzoe to Entheon's Advisory Board
25.08.Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon A..
24.08.Entheon Biomedical Corp. Announces DTC Eligibility
12.08.Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneuro..
12.08.Entheon Biomedical Corp. Announces Sponsorship of a Clinical Study to Assess the Electr..
30.07.ENTHEON BIOMEDICAL : Buys Lobo Genetics
30.07.Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
28.07.Entheon Biomedical Appoints Andy Greenshaw to Advisory Board
28.07.Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Gree..
27.07.Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter Ended May 31, ..
27.07.MICRODOSE IS PLEASED TO ANNOUNCE THE : A Molecular Masterclass
30.06.Entheon Biomedical Corp. Announces the Appointment of Dinesh Bayana as a Medical Adviso..
30.06.Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana
25.06.Entheon Subsidiary, HaluGen Life Sciences, Partners with Maya Health to Drive Psychedel..
23.06.ENTHEON BIOMEDICAL : Subsidiary HaluGen Life Sciences Announces Agreement with Third Wave
22.06.Entheon Biomedical Corp. Announces Agreement with 3W Wellness Inc
22.06.Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third Wa..
17.06.ENTHEON BIOMEDICAL CORP : . Announces Agreement to Acquire Lobo Genetics Inc
17.06.Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences and Silo Wellness A..
17.06.ENTHEON BIOMEDICAL : Silo Wellness and Entheon Biomedical's Wholly-Owned Subsidiary, HaluG..
17.06.Silo Wellness and Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, ..
16.06.Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc.
10.06.Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genet..
18.05.Entheon Biomedical Announces DMT Drug Supply Agreement with Ofichem Group
18.05.Entheon Biomedical Announces DMT Drug Supply Agreement with Ofichem Group
17.05.ENTHEON BIOMEDICAL CORP : . Provides Corporate Update
14.05.Entheon Biomedical Corp. Provides Corporate Update
11.05.Entheon Biomedical Corp. Announces Participation in the Q2 Virtual Investor Summit
07.05.Entheon Biomedical Corp. cancelled the transaction announced on May 7, 2020
05.05.ENTHEON BIOMEDICAL : Up 3.3% after Reporting Listing on OTCQB Venture Market
05.05.Entheon Biomedical Lists on OTCQB Venture Market
28.04.Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February ..
24.04.114,626 Common Shares of MPV Exploration Inc. are subject to a Lock-Up Agreement Ending..
06.04.Entheon Biomedical Corp. Launches HaluGen's Psychedelics Genetic Test
06.04.Entheon Biomedical Corp. Launches HaluGen's Psychedelics Genetic Test
30.03.March Psychedelic Capital Investigates Ethical IP and Financial Instruments
30.03.Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, ..
30.03.Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt
10.03.ELLIS MARTIN REPORT : Entheon Biomedical's (CNSX:ENBI) HaluGen Psychedelics Genetic Test A..
03.03.Entheon Biomedical Corp. Announces Nancy Maher as Special Advisor of Data Science and R..
03.03.Entheon Biomedical Announces Nancy Maher, Special Advisor of Data Science and Regulator..
24.02.Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences
22.02.Entheon Biomedical Announces Ethics Approval for in Vivo DMT Study
22.02.Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study
16.02.Entheon Biomedical Corp. Appoints Dr. Brian Jahns to the Role of Chief Business Officer
16.02.Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian Jahn..
16.02.ELLIS MARTIN REPORT : Entheon Biomedical (CNSX:ENBI) CEO Timothy Ko on the Ethical Clinica..
04.02.Entheon Biomedical Hires ClearTV Executive as VP of Digital Experience Entertainment Ve..
02.02.Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments
22.01.Entheon Biomedical to be Included in First North American Psychedelic ETF
22.01.Entheon Biomedical Corp. to Be Included in First North American Psychedelic ETF
19.01.Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biom..
19.01.Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biom..
14.01.Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc.
14.01.Entheon Biomedical Corp. acquired HaluGen Life Sciences Inc. for CAD 4.2 million.
12.01.Entheon Biomedical Engages Star Finance GmbH for Investor Relations
11.01.Entheon Biomedical Corp. Appoints Scott Keeney as Media Advisor
11.01.Entheon Biomedical Engages World Renowned Media Personality DJ Skee, AKA Scott Keeney, ..
11.01.Entheon Biomedical Corp. announced that it has received CAD 3.214515 million in funding
04.01.Entheon Biomedical Announces Investment and Business Arrangement with Heading Health LL..
04.01.Heading Health LLC announced that it has received $0.2 million in funding from Entheon ..
2020Entheon Biomedical Closes Private Placement
2020Entheon Biomedical Announces Private Placement
2020Entheon Biomedical Corp. announced that it expects to receive CAD 3.200248 million in f..
2020Entheon Biomedical Announces Dmt Drug Supply Agreement with Psygen Labs Inc. Completion..
2020Entheon Biomedical Announces DMT Drug Supply Agreement with Psygen Labs Inc. Completion..
2020Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific
2020Wonder Scientific Inc. announced that it expects to receive funding from Entheon Biomed..
2020Entheon Biomedical Corp. Announces CRO Agreement with Centre for Human Drug Research fo..
2020Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre..
2020Entheon Biomedical to Begin Trading on the Frankfurt Exchange
2020CSE BULLETIN : Fundamental Change - MPV Explorations Inc./Entheon Biomedical Corp.
1  2Weiter